Loading...
Tarsus Pharmaceuticals, Inc.
TARS•NASDAQ
HealthcareBiotechnology
$44.76
$-2.38(-5.05%)
Tarsus Pharmaceuticals, Inc. (TARS) Quarterly Earnings Reports & Financial Results
Analyze Tarsus Pharmaceuticals, Inc.’s revenue, EPS, and earnings surprises to assess performance and investor sentiment over recent quarters.
Total Reports
0
Avg EPS
N/A
Avg Revenue
N/A
Beats Estimates
0 out of 0
Max EPS
N/A
Min EPS
N/A
Earnings Visualization
Visual comparison of Tarsus Pharmaceuticals, Inc.’s actual vs. estimated earnings across recent quarters.
No data available
Tarsus Pharmaceuticals, Inc. (TARS) Quarterly Earnings Details
Detailed breakdown of Tarsus Pharmaceuticals, Inc.’s earnings per share (EPS), revenue estimates vs. actuals, and earnings surprises by quarter.